APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cardiac AI-assisted Diagnosis

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cardiac AI-assisted Diagnosis Market Outlook and Growth Opportunities 2026

6 March 2026205 pages

Choose your research edition.

Industry ResearchCardiac AI-assisted Diagnosis Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiac AI-assisted Diagnosis Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Cardiac AI-assisted Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiac AI-assisted Diagnosis Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Cardiac AI-assisted Diagnosis Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Cardiac AI-assisted Diagnosis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cardiac AI-assisted Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cardiac AI-assisted Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cardiac AI-assisted Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cardiac AI-assisted Diagnosis market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cardiac AI-assisted Diagnosis market include Lepu Medical, G K Healthcare, Sense Time, United Imaging, Infervision, Shukun, FOSUN AITROX, NANO-X and MyCardium AI, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cardiac AI-assisted Diagnosis market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cardiac AI-assisted Diagnosis and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cardiac AI-assisted Diagnosis revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cardiac AI-assisted Diagnosis market.

Cardiac AI-assisted Diagnosis Segment by Company

Lepu Medical

G K Healthcare

Sense Time

United Imaging

Infervision

Shukun

FOSUN AITROX

NANO-X

MyCardium AI

VUNO

Caption Care

UltraSight

Ultromics

Cleerly

Elucid

DiA Imaging Analysis

Koninklijke Philips N.V

Fujifilm

Cardiac AI-assisted Diagnosis Segment by Type

Cloud-based

On-Primes

Cardiac AI-assisted Diagnosis Segment by Application

Hospital

Clinic

Imaging Center

Cardiac AI-assisted Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cardiac AI-assisted Diagnosis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cardiac AI-assisted Diagnosis key companies, revenue, market share, and recent developments.

3. To split the Cardiac AI-assisted Diagnosis breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cardiac AI-assisted Diagnosis market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cardiac AI-assisted Diagnosis significant trends, drivers, influence factors in global and regions.

6. To analyze Cardiac AI-assisted Diagnosis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiac AI-assisted Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiac AI-assisted Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiac AI-assisted Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cardiac AI-assisted Diagnosis industry.

Chapter 3: Detailed analysis of Cardiac AI-assisted Diagnosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cardiac AI-assisted Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cardiac AI-assisted Diagnosis in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cardiac AI-assisted Diagnosis Industry Trends Table 2. Cardiac AI-assisted Diagnosis Industry Drivers Table 3. Cardiac AI-assisted Diagnosis Industry Opportunities and Challenges Table 4. Cardiac AI-assisted Diagnosis Industry Restraints Table 5. Global Cardiac AI-assisted Diagnosis Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cardiac AI-assisted Diagnosis Revenue Share by Company (2021-2026) Table 7. Global Cardiac AI-assisted Diagnosis Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cardiac AI-assisted Diagnosis Key Company Manufacturing Base & Headquarters Table 9. Global Cardiac AI-assisted Diagnosis Company, Product Type & Application Table 10. Global Cardiac AI-assisted Diagnosis Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cardiac AI-assisted Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud-based Table 15. Significant Companies of On-Primes Table 16. Global Cardiac AI-assisted Diagnosis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Cardiac AI-assisted Diagnosis Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Cardiac AI-assisted Diagnosis Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Cardiac AI-assisted Diagnosis Sales Value Share by Type (2021-2026) Table 20. Global Cardiac AI-assisted Diagnosis Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Clinic Table 23. Significant Companies of Imaging Center Table 24. Global Cardiac AI-assisted Diagnosis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Cardiac AI-assisted Diagnosis Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Cardiac AI-assisted Diagnosis Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Cardiac AI-assisted Diagnosis Sales Value Share by Application (2021-2026) Table 28. Global Cardiac AI-assisted Diagnosis Sales Value Share by Application (2027-2032) Table 29. Global Cardiac AI-assisted Diagnosis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Cardiac AI-assisted Diagnosis Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Cardiac AI-assisted Diagnosis Sales Value Share by Region (2021-2026) Table 32. Global Cardiac AI-assisted Diagnosis Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Cardiac AI-assisted Diagnosis Sales Value Share by Region (2027-2032) Table 34. Global Cardiac AI-assisted Diagnosis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Cardiac AI-assisted Diagnosis Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Cardiac AI-assisted Diagnosis Sales Value Market Share by Country (2021-2026) Table 37. Global Cardiac AI-assisted Diagnosis Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Cardiac AI-assisted Diagnosis Sales Value Market Share by Country (2027-2032) Table 39. Lepu Medical Company Information Table 40. Lepu Medical Business Overview Table 41. Lepu Medical Cardiac AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Lepu Medical Cardiac AI-assisted Diagnosis Product Portfolio Table 43. Lepu Medical Recent Development Table 44. G K Healthcare Company Information Table 45. G K Healthcare Business Overview Table 46. G K Healthcare Cardiac AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. G K Healthcare Cardiac AI-assisted Diagnosis Product Portfolio Table 48. G K Healthcare Recent Development Table 49. Sense Time Company Information Table 50. Sense Time Business Overview Table 51. Sense Time Cardiac AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Sense Time Cardiac AI-assisted Diagnosis Product Portfolio Table 53. Sense Time Recent Development Table 54. United Imaging Company Information Table 55. United Imaging Business Overview Table 56. United Imaging Cardiac AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. United Imaging Cardiac AI-assisted Diagnosis Product Portfolio Table 58. United Imaging Recent Development Table 59. Infervision Company Information Table 60. Infervision Business Overview Table 61. Infervision Cardiac AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Infervision Cardiac AI-assisted Diagnosis Product Portfolio Table 63. Infervision Recent Development Table 64. Shukun Company Information Table 65. Shukun Business Overview Table 66. Shukun Cardiac AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Shukun Cardiac AI-assisted Diagnosis Product Portfolio Table 68. Shukun Recent Development Table 69. FOSUN AITROX Company Information Table 70. FOSUN AITROX Business Overview Table 71. FOSUN AITROX Cardiac AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. FOSUN AITROX Cardiac AI-assisted Diagnosis Product Portfolio Table 73. FOSUN AITROX Recent Development Table 74. NANO-X Company Information Table 75. NANO-X Business Overview Table 76. NANO-X Cardiac AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. NANO-X Cardiac AI-assisted Diagnosis Product Portfolio Table 78. NANO-X Recent Development Table 79. MyCardium AI Company Information Table 80. MyCardium AI Business Overview Table 81. MyCardium AI Cardiac AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. MyCardium AI Cardiac AI-assisted Diagnosis Product Portfolio Table 83. MyCardium AI Recent Development Table 84. VUNO Company Information Table 85. VUNO Business Overview Table 86. VUNO Cardiac AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. VUNO Cardiac AI-assisted Diagnosis Product Portfolio Table 88. VUNO Recent Development Table 89. Caption Care Company Information Table 90. Caption Care Business Overview Table 91. Caption Care Cardiac AI-assisted Diagnosis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Caption Care Cardiac AI-assisted Diagnosis Product Portfolio Table 93. Caption Care Recent Development Table 94. UltraSight Company Information Table 95. UltraSight Business Overview Table 96. UltraSight Cardiac AI-assisted Diagnosis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. UltraSight Cardiac AI-assisted Diagnosis Product Portfolio Table 98. UltraSight Recent Development Table 99. Ultromics Company Information Table 100. Ultromics Business Overview Table 101. Ultromics Cardiac AI-assisted Diagnosis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Ultromics Cardiac AI-assisted Diagnosis Product Portfolio Table 103. Ultromics Recent Development Table 104. Cleerly Company Information Table 105. Cleerly Business Overview Table 106. Cleerly Cardiac AI-assisted Diagnosis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Cleerly Cardiac AI-assisted Diagnosis Product Portfolio Table 108. Cleerly Recent Development Table 109. Elucid Company Information Table 110. Elucid Business Overview Table 111. Elucid Cardiac AI-assisted Diagnosis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Elucid Cardiac AI-assisted Diagnosis Product Portfolio Table 113. Elucid Recent Development Table 114. DiA Imaging Analysis Company Information Table 115. DiA Imaging Analysis Business Overview Table 116. DiA Imaging Analysis Cardiac AI-assisted Diagnosis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. DiA Imaging Analysis Cardiac AI-assisted Diagnosis Product Portfolio Table 118. DiA Imaging Analysis Recent Development Table 119. Koninklijke Philips N.V Company Information Table 120. Koninklijke Philips N.V Business Overview Table 121. Koninklijke Philips N.V Cardiac AI-assisted Diagnosis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Koninklijke Philips N.V Cardiac AI-assisted Diagnosis Product Portfolio Table 123. Koninklijke Philips N.V Recent Development Table 124. Fujifilm Company Information Table 125. Fujifilm Business Overview Table 126. Fujifilm Cardiac AI-assisted Diagnosis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Fujifilm Cardiac AI-assisted Diagnosis Product Portfolio Table 128. Fujifilm Recent Development Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Cardiac AI-assisted Diagnosis Product Image Figure 2. Global Cardiac AI-assisted Diagnosis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cardiac AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 4. Global Cardiac AI-assisted Diagnosis Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud-based Image Figure 8. On-Primes Image Figure 9. Global Cardiac AI-assisted Diagnosis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Cardiac AI-assisted Diagnosis Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Cardiac AI-assisted Diagnosis Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Imaging Center Image Figure 15. Global Cardiac AI-assisted Diagnosis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Cardiac AI-assisted Diagnosis Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Cardiac AI-assisted Diagnosis Sales Value Share by Application (2021-2032) Figure 18. Global Cardiac AI-assisted Diagnosis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Cardiac AI-assisted Diagnosis Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Cardiac AI-assisted Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 21. North America Cardiac AI-assisted Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Cardiac AI-assisted Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Cardiac AI-assisted Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Cardiac AI-assisted Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Cardiac AI-assisted Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Cardiac AI-assisted Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 27. South America Cardiac AI-assisted Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Cardiac AI-assisted Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Cardiac AI-assisted Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-Primes
Applications
  • Hospital
  • Clinic
  • Imaging Center
Companies covered
  • Lepu Medical
  • G K Healthcare
  • Sense Time
  • United Imaging
  • Infervision
  • Shukun
  • FOSUN AITROX
  • NANO-X
  • MyCardium AI
  • VUNO
  • Caption Care
  • UltraSight
  • Ultromics
  • Cleerly
  • Elucid
  • DiA Imaging Analysis
  • Koninklijke Philips N.V
  • Fujifilm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cardiac AI-assisted Diagnosis Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cardiac AI-assisted Diagnosis Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cardiac AI-assisted Diagnosis Market Dynamics
  1. 2.1 Cardiac AI-assisted Diagnosis Industry Trends
  2. 2.2 Cardiac AI-assisted Diagnosis Industry Drivers
  3. 2.3 Cardiac AI-assisted Diagnosis Industry Opportunities and Challenges
  4. 2.4 Cardiac AI-assisted Diagnosis Industry Restraints
3 Cardiac AI-assisted Diagnosis Market by Company
  1. 3.1 Global Cardiac AI-assisted Diagnosis Company Revenue Ranking in 2025
  2. 3.2 Global Cardiac AI-assisted Diagnosis Revenue by Company (2021-2026)
  3. 3.3 Global Cardiac AI-assisted Diagnosis Company Ranking (2024-2026)
  4. 3.4 Global Cardiac AI-assisted Diagnosis Company Manufacturing Base and Headquarters
  5. 3.5 Global Cardiac AI-assisted Diagnosis Company Product Type and Application
  6. 3.6 Global Cardiac AI-assisted Diagnosis Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cardiac AI-assisted Diagnosis Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cardiac AI-assisted Diagnosis Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cardiac AI-assisted Diagnosis Market by Type
  1. 4.1 Cardiac AI-assisted Diagnosis Type Introduction
  2. 4.1.1 Cloud-based
  3. 4.1.2 On-Primes
  4. 4.2 Global Cardiac AI-assisted Diagnosis Sales Value by Type
  5. 4.2.1 Global Cardiac AI-assisted Diagnosis Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cardiac AI-assisted Diagnosis Sales Value by Type (2021-2032)
  7. 4.2.3 Global Cardiac AI-assisted Diagnosis Sales Value Share by Type (2021-2032)
5 Cardiac AI-assisted Diagnosis Market by Application
  1. 5.1 Cardiac AI-assisted Diagnosis Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Imaging Center
  5. 5.2 Global Cardiac AI-assisted Diagnosis Sales Value by Application
  6. 5.2.1 Global Cardiac AI-assisted Diagnosis Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cardiac AI-assisted Diagnosis Sales Value by Application (2021-2032)
  8. 5.2.3 Global Cardiac AI-assisted Diagnosis Sales Value Share by Application (2021-2032)
6 Cardiac AI-assisted Diagnosis Regional Value Analysis
  1. 6.1 Global Cardiac AI-assisted Diagnosis Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cardiac AI-assisted Diagnosis Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cardiac AI-assisted Diagnosis Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cardiac AI-assisted Diagnosis Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cardiac AI-assisted Diagnosis Sales Value (2021-2032)
  7. 6.3.2 North America Cardiac AI-assisted Diagnosis Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cardiac AI-assisted Diagnosis Sales Value (2021-2032)
  10. 6.4.2 Europe Cardiac AI-assisted Diagnosis Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cardiac AI-assisted Diagnosis Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cardiac AI-assisted Diagnosis Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cardiac AI-assisted Diagnosis Sales Value (2021-2032)
  16. 6.6.2 South America Cardiac AI-assisted Diagnosis Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cardiac AI-assisted Diagnosis Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cardiac AI-assisted Diagnosis Sales Value Share by Country, 2025 VS 2032
7 Cardiac AI-assisted Diagnosis Country-level Value Analysis
  1. 7.1 Global Cardiac AI-assisted Diagnosis Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cardiac AI-assisted Diagnosis Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cardiac AI-assisted Diagnosis Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cardiac AI-assisted Diagnosis Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cardiac AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cardiac AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cardiac AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lepu Medical
  2. 8.1.1 Lepu Medical Company Information
  3. 8.1.2 Lepu Medical Business Overview
  4. 8.1.3 Lepu Medical Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Lepu Medical Cardiac AI-assisted Diagnosis Product Portfolio
  6. 8.1.5 Lepu Medical Recent Developments
  7. 8.2 G K Healthcare
  8. 8.2.1 G K Healthcare Company Information
  9. 8.2.2 G K Healthcare Business Overview
  10. 8.2.3 G K Healthcare Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  11. 8.2.4 G K Healthcare Cardiac AI-assisted Diagnosis Product Portfolio
  12. 8.2.5 G K Healthcare Recent Developments
  13. 8.3 Sense Time
  14. 8.3.1 Sense Time Company Information
  15. 8.3.2 Sense Time Business Overview
  16. 8.3.3 Sense Time Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sense Time Cardiac AI-assisted Diagnosis Product Portfolio
  18. 8.3.5 Sense Time Recent Developments
  19. 8.4 United Imaging
  20. 8.4.1 United Imaging Company Information
  21. 8.4.2 United Imaging Business Overview
  22. 8.4.3 United Imaging Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  23. 8.4.4 United Imaging Cardiac AI-assisted Diagnosis Product Portfolio
  24. 8.4.5 United Imaging Recent Developments
  25. 8.5 Infervision
  26. 8.5.1 Infervision Company Information
  27. 8.5.2 Infervision Business Overview
  28. 8.5.3 Infervision Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Infervision Cardiac AI-assisted Diagnosis Product Portfolio
  30. 8.5.5 Infervision Recent Developments
  31. 8.6 Shukun
  32. 8.6.1 Shukun Company Information
  33. 8.6.2 Shukun Business Overview
  34. 8.6.3 Shukun Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shukun Cardiac AI-assisted Diagnosis Product Portfolio
  36. 8.6.5 Shukun Recent Developments
  37. 8.7 FOSUN AITROX
  38. 8.7.1 FOSUN AITROX Company Information
  39. 8.7.2 FOSUN AITROX Business Overview
  40. 8.7.3 FOSUN AITROX Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  41. 8.7.4 FOSUN AITROX Cardiac AI-assisted Diagnosis Product Portfolio
  42. 8.7.5 FOSUN AITROX Recent Developments
  43. 8.8 NANO-X
  44. 8.8.1 NANO-X Company Information
  45. 8.8.2 NANO-X Business Overview
  46. 8.8.3 NANO-X Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  47. 8.8.4 NANO-X Cardiac AI-assisted Diagnosis Product Portfolio
  48. 8.8.5 NANO-X Recent Developments
  49. 8.9 MyCardium AI
  50. 8.9.1 MyCardium AI Company Information
  51. 8.9.2 MyCardium AI Business Overview
  52. 8.9.3 MyCardium AI Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  53. 8.9.4 MyCardium AI Cardiac AI-assisted Diagnosis Product Portfolio
  54. 8.9.5 MyCardium AI Recent Developments
  55. 8.10 VUNO
  56. 8.10.1 VUNO Company Information
  57. 8.10.2 VUNO Business Overview
  58. 8.10.3 VUNO Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  59. 8.10.4 VUNO Cardiac AI-assisted Diagnosis Product Portfolio
  60. 8.10.5 VUNO Recent Developments
  61. 8.11 Caption Care
  62. 8.11.1 Caption Care Company Information
  63. 8.11.2 Caption Care Business Overview
  64. 8.11.3 Caption Care Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Caption Care Cardiac AI-assisted Diagnosis Product Portfolio
  66. 8.11.5 Caption Care Recent Developments
  67. 8.12 UltraSight
  68. 8.12.1 UltraSight Company Information
  69. 8.12.2 UltraSight Business Overview
  70. 8.12.3 UltraSight Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  71. 8.12.4 UltraSight Cardiac AI-assisted Diagnosis Product Portfolio
  72. 8.12.5 UltraSight Recent Developments
  73. 8.13 Ultromics
  74. 8.13.1 Ultromics Company Information
  75. 8.13.2 Ultromics Business Overview
  76. 8.13.3 Ultromics Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Ultromics Cardiac AI-assisted Diagnosis Product Portfolio
  78. 8.13.5 Ultromics Recent Developments
  79. 8.14 Cleerly
  80. 8.14.1 Cleerly Company Information
  81. 8.14.2 Cleerly Business Overview
  82. 8.14.3 Cleerly Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Cleerly Cardiac AI-assisted Diagnosis Product Portfolio
  84. 8.14.5 Cleerly Recent Developments
  85. 8.15 Elucid
  86. 8.15.1 Elucid Company Information
  87. 8.15.2 Elucid Business Overview
  88. 8.15.3 Elucid Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Elucid Cardiac AI-assisted Diagnosis Product Portfolio
  90. 8.15.5 Elucid Recent Developments
  91. 8.16 DiA Imaging Analysis
  92. 8.16.1 DiA Imaging Analysis Company Information
  93. 8.16.2 DiA Imaging Analysis Business Overview
  94. 8.16.3 DiA Imaging Analysis Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  95. 8.16.4 DiA Imaging Analysis Cardiac AI-assisted Diagnosis Product Portfolio
  96. 8.16.5 DiA Imaging Analysis Recent Developments
  97. 8.17 Koninklijke Philips N.V
  98. 8.17.1 Koninklijke Philips N.V Company Information
  99. 8.17.2 Koninklijke Philips N.V Business Overview
  100. 8.17.3 Koninklijke Philips N.V Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Koninklijke Philips N.V Cardiac AI-assisted Diagnosis Product Portfolio
  102. 8.17.5 Koninklijke Philips N.V Recent Developments
  103. 8.18 Fujifilm
  104. 8.18.1 Fujifilm Company Information
  105. 8.18.2 Fujifilm Business Overview
  106. 8.18.3 Fujifilm Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Fujifilm Cardiac AI-assisted Diagnosis Product Portfolio
  108. 8.18.5 Fujifilm Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst